Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer
Cancer Medicine · 2023-11 · 12 (21) · 20573-20589
DOI: 10.1002/cam4.6623 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 20.10.2023. Verfasst von Xiangwen Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Ferroptosis, Gastrointestinal Neoplasms, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Gastrointestinal cancer poses a serious health threat owing to its high morbidity and mortality. Although immune checkpoint blockade (ICB) therapies have achieved meaningful success in most solid tumors, the improvement in survival in gastrointestinal cancers is modest, owing to sparse immune response and widespread resistance. Metabolic reprogramming, autophagy, and ferroptosis are key regulators of tumor progression.
Methods
A literature review was conducted to investigate the role of the metabolic reprogramming, autophagy, and ferroptosis in immunotherapy resistance of gastrointestinal cancer.
Results
Metabolic reprogramming, autophagy, and ferroptosis play pivotal roles in regulating the survival, differentiation, and function of immune cells within the tumor microenvironment. These processes redefine the nutrient allocation blueprint between cancer cells and immune cells, facilitating tumor immune evasion, which critically impacts the therapeutic efficacy of immunotherapy for gastrointestinal cancers. Additionally, there exists profound crosstalk among metabolic reprogramming, autophagy, and ferroptosis. These interactions are paramount in anti‐tumor immunity, further promoting the formation of an immunosuppressive microenvironment and resistance to immunotherapy.
Conclusions
Consequently, it is imperative to conduct comprehensive research on the roles of metabolic reprogramming, autophagy, and ferroptosis in the resistance of gastrointestinal tumor immunotherapy. This understanding will illuminate the clinical potential of targeting these pathways and their regulatory mechanisms to overcome immunotherapy resistance in gastrointestinal cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
- Department of Stomatology, The First Hospital of Lanzhou University, Lanzhou, China.
ORCID-Profile: Jun Wang
Zitieren
APA
Wang, X., Zhou, L., Wang, H., Chen, W., Jiang, L., Ming, G., & Wang, J. (2023). Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer. Cancer Medicine, 12(21), 20573-20589. https://doi.org/10.1002/cam4.6623
Vancouver
Wang X, Zhou L, Wang H, Chen W, Jiang L, Ming G, et al. Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer. Cancer Medicine. 2023;12(21):20573-20589. doi:10.1002/cam4.6623
BibTeX
@article{Wang2023,
author = {Wang, Xiangwen and Zhou, Liwen and Wang, Hongpeng and Chen, Wei and Jiang, Lei and Ming, Guangtao and Wang, Jun},
title = {Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {21},
pages = {20573--20589},
doi = {10.1002/cam4.6623}
}
EUVIMED